Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VREX · against 437 other Healthcare companies of similar size
Ranked #98 of 438 · scores higher than 77% of peers
Bars: peers in each 10-point band of the growth score47 peers with a growth score of 70–79, including VREX · Click a bar to see the companies
Mainly thanks to its earnings per share growth, which is stronger than most Healthcare peers.
| Metric | VREX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 449 reported | 5.3% | 3.4% | 55% | 33% | |
| Earnings per share growthHigher is better · 243 reported | Not reported | 5.5% | — | — | 33% |
| 3-year revenue growthHigher is better · 432 reported | -1.2% | 4.6% | 32% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 96 | 6.4B CNY (≈$894M) | 74 | 60 | |
| 98 | 10.2B CNY (≈$1.4B) | 73 | 71 | |
| 98 | 4.3B CNY (≈$596M) | 73 | 56 | |
| 98 | 212.3B JPY (≈$1.4B) | 73 | 62 | |
| 98 | 787M USD | 73 | 57 | |
| 102 | 8.7B CNY (≈$1.2B) | 72 | 77 | |
| 102 | 70.2B JPY (≈$477M) | 72 | 59 | |
| 102 | 118.0B INR (≈$1.4B) | 72 | 68 | |
| 102 | 561M USD | 72 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score